Business Wire

GLOBAL-RAYTUR

11.5.2018 04:02:08 CEST | Business Wire | Press release

Share
31st World Ports Conference Emblem Launched at Baku, Azerbaijan

On May 9th , the mid-term conference of the World Ports Conference was held by International Association of Ports and Harbors (IAPH) in Baku, Azerbaijan. Over 300 ports and port-related companies and organizations worldwide participated in the Conference. As the host for World Ports Conference 2019 and an important foreign trade port of China, Guangzhou Port Authority extended its warm invitation to all guests.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180510006415/en/

To host World Ports Conference 2019 is a milestone for Guangzhou Port. It is also an important step to accelerate the construction and development of national central cities and shipping hubs and the forming of a new pattern of all-around opening up in China. Ms.Yuan stated that “the development of the port cannot be separated from the city. It is even more than just cooperation with the port sector. Instead, the projects should be the trigger activating trades, logistics, ports and other departments to jointly develop and standardize the ports.” She also mentioned that during 31st World Ports Conference in Guangzhou next year the host will launch the ‘Friend Circle’ Initiative for ports along ‘Belt and Road’ to promote trade facilitation and internationalization of Chinese standards.

This time Guangzhou Port Authority chose “Collaborate Now, Create Future” as the theme in its exhibition area, where fully demonstrated the port of Guangzhou as an international shipping hub which is always dedicated to improving modern shipping logistics services and building a smart green and safe port, as well as deepening the exchanges and cooperation internationally. Guangzhou Port Authority also signed a sister port cooperation agreement with Baku International Sea Trade Port, who becomes the 42nd sister port of Guangzhou. Thanks to the conferences of IAPH, Guangzhou Port now maintains friendly cooperation with over 100 countries and 400 ports worldwide.

Since the issuance of the "Three-Year Action Plan for the Construction of the Guangzhou International Shipping Center" in 2015, three years of hard work has led to a big leap in port production, the gathering and radiation power has expanded, new breakthroughs have been made in factor gathering, and key projects such as the Nansha International Cruise Terminal have kicked off. The construction will add new momentum to the gateway hub. China (Guangzhou) International Freight single window has become a leading and demonstrative example among its peers in China.

With the launch of the new 3-year Action Plan, the port of Guangzhou will use the port as a fulcrum to strengthen the connectivity with the regions and cities along the “Belt and Road” initiative, and rapidly enhance the internationalization process of Guangzhou Port. By strictly following the “Belt and Road” initiative and grasping the opportunities of the policy of building a powerful country with strong traffic, powerful oceans, as well as the Bay Area construction of Guangdong, Hong Kong, and Macao, multiple measures will be taken together to promote the construction of the Guangzhou International Shipping Center and jointly create a world-class shipping hub.

Contact:

Global Raytur (Beijing) Public Communication Co.,Ltd
Shirley
86 13720002197
wangyishan@globalraytur.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye